Herbalife shares seen as a 'risky' buy with potential upside despite mixed sales and leverage concerns.

Herbalife Ltd. is rated as a 'risky' Buy due to shares trading at a significant discount and the market's overly pessimistic outlook on its long-term decline. The company posted four consecutive quarters of year-over-year net sales growth, mainly driven by a one-time GST cut in India, while other regions showed mixed or declining sales volumes. Herbalife is repositioning strategically towards personalized nutrition and has reduced its net leverage to 2.2x, unlocking $45 million in annual cash interest savings. Despite risks from factors like GLP-1 adoption, growth concentration, leverage, and regulatory exposure, the current share price offers potential upside compared to a base case fair value near $24.